New Randomized Double-Blind Clinical Study Shows Oska Pulse Significantly Reduces Pain
CARLSBAD, Calif., Feb. 6, 2018 /PRNewswire/ — Oska Wellness, a technology company committed to developing consumer health and wellness products, has released the results of a randomized double-blind placebo study showing significant results in pain reduction by using Oska Pulse.
The clinical trial was completed at the Virtual Reality Medical Center, Scripps Memorial Hospital, in La Jolla, Californiaand conducted by a respected team of doctors: Dr. Joseph Shurman, Dr. Brenda K. Wiederhold, Dr. Roger Kasendorf, Dr. John Qian, and Dr. Mark D. Wiederhold. The detailed findings have been published here, the Practical Pain Management Journal website, which offers current, useful, and practical information for patients living with chronic pain, and for the medical professionals who treat them.
“We were very encouraged with this trial and it has provided valuable information on how PEMF therapy can treat chronic pain,” said Dr. Brenda Wiederhold. “With the opioid epidemic, it is really timely to find other non-narcotic pain relief solutions for patients.”
“I am very excited as the study confirms that using the Oska Pulse is a true pain relief device regardless of the user(s) background.” Greg Houlgate, President and CEO of Oska Wellness. “Oska Pulse is providing relief for many early users of the product by helping to reduce back, shoulder, knee, ankle, and foot pain, as well as chronic pain issues. The feedback from this double-blind study confirms that Oska Pulse can really help people dealing with pain.”